Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trialClaus Rödel, Torsten Liersch, Ullrich Graeven et al.|The Lancet Oncology|2015Cited by 723
SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemiaConstanze Schneider, Jindřich Činátl, Hanibal Bohnenberger et al.|Nature Medicine|2016Cited by 185
<i>TFAP2E–DKK4</i> and Chemoresistance in Colorectal CancerMatthias Ebert, Roland M. Schmid, Marc Tänzer et al.|New England Journal of Medicine|2012Cited by 184